cobenfy bristol myers news

Bristol Myers wins US FDA approval for new type of schizophrenia drug

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades.

BioPharma Dive · 2d

Approval in hand, Bristol Myers sets out to sell first-of-its-kind schizophrenia drug

While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

Investor's Business Daily on MSN · 3d

Bristol-Myers Squibb's Novel Schizophrenia Drug Wins FDA Approval; BMY Stock Set To Break Out

Bristol-Myers Squibb won FDA approval for its novel schizophrenia drug, Cobenfy. BMY stock jumped, signaling a breakout.

11hon MSN

Bristol Myers gets $6.4B Celgene CVR case dismissed: report

A federal court in New York has reportedly dismissed a $6.4B suit against Bristol Myers Squibb (NYSE:BMY) that alleged the ...

bovnews16h

BMY’s Latest Twist: What’s Fueling the Unexpected Shifts in Bristol-Myers Squibb Co’s Stock Price?

On Friday, Bristol-Myers Squibb Co (BMY) stock saw a modest uptick, ending the day at $50.91 which represents a slight increase of $0.79 or 1.58% from the prior close of $50.12. The stock opened at ...

MarketWatch5d

2seventy, Bristol Myers Drop Abecma Study in Newly Diagnosed Patients

2seventy bio and Bristol Myers Squibb are pulling the plug on a late-stage study of their Abecma gene therapy in certain people newly diagnosed with the blood cancer multiple myeloma. 2seventy on ...

21h

Week 3 Connecticut high school football top performers

Here are the top performances in football from last week. Please email your top performers each week to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics